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Summary
Zika virus (ZIKV) remained obscure until the recent explosive outbreaks in French Polynesia
(2013-2014) and South America (2015-2016). Phylogenetic studies reveal that ZIKV has evolved
into African and Asian lineages. The Asian lineage of ZIKV is responsible for the recent
epidemics in the Americas. However, the underlying mechanisms through which ZIKV rapidly
and explosively spread from Asia to the Americas are limited. We have recently shown that
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nonstructural protein 1 (NS1) facilitates flavivirus acquisition by mosquitoes from an infected
mammalian host and subsequently enhances viral prevalence in mosquitoes. Here, we report that
the antigenemia of NS1 determines ZIKV infectivity in its mosquito vector Aedes aegypti, which
acquires ZIKV via a blood meal. Clinical isolates from the most recent outbreak in the Americas
were much more infectious in mosquitoes than the FSS13025 strain, which was isolated in
Cambodia in 2010. Further analyses showed that these epidemic strains have more robust NS1
antigenemia than the FSS13025 strain because of an alanine-to-valine amino acid substitution at
the 188th residue in NS1. ZIKV infectivity was enhanced by this residue substitution in the ZIKV
FSS13025 strain in mosquitoes that acquired ZIKV from a viremic Type I and II interferon
receptor-deficient (ifnagr-/-) C57BL/6 (AG6) mouse. Our results reveal that ZIKV evolved to
acquire a spontaneous mutation in its NS1 protein, resulting in increased antigenemia of the
protein. Enhancement of NS1 antigenemia in infected hosts promotes ZIKV infectivity and
prevalence in mosquitoes, which potentially facilitates transmission during the recent ZIKV
epidemics.
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Zika virus (ZIKV), a mosquito-borne virus belonging to the genus Flavivirus of the family
Flaviviridae, is transmitted to humans by Aedes mosquito species1,2. Several neurological
complications, such as Guillain-Barré syndrome in adults3 and microcephaly in neonates4,
are potentially associated with ZIKV infection. Before 2007, cases of ZIKV infection were
only sporadically detected2,5. The first reported mild ZIKV outbreak occurred in 2007 on a
Western Pacific Micronesian Yap Island6. In 2013, a larger ZIKV epidemic was recorded in
French Polynesia and other Southern Pacific islands7,8. In 2015, ZIKV emerged in the
Americas for the first time, rapidly spreading to 20 countries or territories9. Phylogenetic
studies have revealed that ZIKV has evolved into African and Asian clusters2,9. Sequence
analyses revealed that the ZIKV strains causing earlier outbreaks in Micronesia (2007) and
French Polynesia (2013-2014) and later outbreaks in the Americas (2015-2016) all belong to
the Asian clade2, suggesting that increased infectivity of the Asian ZIKV lineage might
contribute to the recent worldwide epidemic.
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Evolutionary enhancement of infectivity of mosquito-borne viruses within their vectors
results in high epidemic potential10,11. We speculate that the adaptability and infectivity of
ZIKV within its mosquito vectors might have evolved with time, contributing to the
prevalence and spread of the virus from Asia to the Americas. To test this hypothesis, we
compared the viral infectivity of two clinical ZIKV isolates of the Asian lineage, GZ01
isolated in 201612 and FSS13025 in 201013, in the primary urban mosquito vector, Aedes
aegypti. Phylogenetic analysis shows that these 2 strains represent the clades corresponding
to the epidemic strains of ZIKV that are prevalent in Americas (2015-2016) and the
Southeastern Asia (2007-2012) (Extended Data Fig. 1). Thus, we exploited a "hostmosquito" acquisition model to assess the infectivity of these ZIKV strains, via mosquitoes
acquiring ZIKV from a viremic AG6 mouse 14–16 (Fig. 1a). Both strains exhibited similar
replication kinetics in the infected AG6 mouse blood (Fig. 1b). However, the serum level of
secreted nonstructural protein 1 (NS1) in the FSS13025-infected AG6 mice was much lower
(Fig. 1c). The infected mice were subjected to daily biting by the Rockefeller laboratory
strain of A. aegypti from days 1 to 5 post-mouse infection (Fig. 1a). Compared to the GZ01
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strain, the FSS13025 strain had a significantly lower infection prevalence in the mosquitoes
that fed on the infected mice (Fig. 1d, e).
Secretion of NS1, a virus-encoded nonstructural protein, into the serum of an infected host is
a common property of many flaviviruses15,17–20. Our previous study demonstrated that
circulating NS1 acquired by mosquitoes together with virions when mosquitoes feed on a
viremic mammalian host enhances viral infectivity15. NS1 antigenemia plays a key role in
maintaining the flavivirus life cycle15. We hypothesize that NS1 antigenemia is responsible
for the differential mosquito infectivity between the GZ01 and FSS13025 strains. We
therefore infected Vero cells with the American isolates GZ01 and PRVABC5921, the SZ01
strain representing the French Polynesian clade22, and the FSS13025 strain. Three postepidemic strains showed higher NS1 secretion than the FSS13025 strain (Fig. 2a–c), even
when NS1 amount was normalized to viral titer (Fig. 2c).
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To determine whether NS1 secretability correlates with ZIKV infectivity in mosquitoes, we
generated a murine NS1 polyclonal antibody (Extended Data Fig. 2a). Neutralization of NS1
via the antibody treatment reduced the mosquito infection prevalence of the GZ01 strain
(Fig. 2d–f). The murine NS1 antibodies did not neutralize ZIKV virions (Extended Data Fig.
3). We also determined whether the addition of NS1 protein could enhance ZIKV infectivity.
A recombinant GZ01 NS1 protein was expressed and purified using a Drosophila S2
expression system (Extended Data Fig. 2b). The presence of NS1 increased the infectivity of
the FSS13025 strain in mosquitoes (Fig. 2g–i). We next assessed the threshold concentration
of NS1 that can effectively enhance ZIKV acquisition. Compared to BSA, the presence of
100 ng/ml or higher concentrations of NS1 significantly increased the ZIKV prevalence in
A. aegypti (Fig. 2j–l). To determine the role of animal NS1 antigenemia in ZIKV infectivity
in mosquitoes, we allowed mosquitoes to feed on viremic AG6 mice (Extended Data Fig.
4a). The NS1 antisera treatment reduced the quantity of circulating NS1 in mouse serum
(Extended Data Fig. 4b) but did not influence GZ01 ZIKV replication in AG6 mice
(Extended Data Fig. 4c). The infection ratios of fed A. aegypti were reduced as a result of
the antisera-mediated neutralization of the NS1 in mice (Extended Data Fig. 4d, e).
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Considering the differential secretability of NS1 between the GZ01 and FSS13025 strains
(Fig. 1c and Fig. 2a–c), we next attempted to identify the amino acids critical for NS1
secretion. We focused on the ER transmembrane region of pre-Membrane (prM), the full
length of Envelope (E), and NS1 (prM-E-NS1)23 (Fig. 3a). There are only two variable sites
between the GZ01 and FSS13025 prM-E-NS1 proteins, including the 473rd residue in the E
protein (Val/FSS13025 to Met/GZ01) and the 188th residue in the NS1 protein (Ala/
FSS13025 to Val/GZ01) (Fig. 3a). We therefore individually subcloned the prM-E-NS1
region from the GZ01 and FSS13025 strains and subsequently transfected these segments
into 293T cells. Ectopic expression of the GZ01 prM-E-NS1 protein, but not the FSS13025
protein, led to abundant NS1 secretion in the supernatants of transfected cells (Fig. 3b).
Mutation from valine to methionine at the 473rd residue of the E protein in the FSS13025
prM-E-NS1 protein did not improve NS1 secretion; however, the alanine to valine
substitution at the NS1 188th residue rendered NS1 secretable (Fig. 3b), demonstrating that
this single mutation determines NS1 secretability. The 188th residue is located within
interface between two NS1 monomers24 (Extended Data Fig. 5a). Nonetheless, the alanine-
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to-valine substitution at position 188 does not influence NS1 dimerization (Extended Data
Fig. 5b), suggesting that the mechanism how the single mutation affects NS1 remains to be
defined.
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We next performed an alignment of the NS1 proteins from the Asian clade of ZIKV. In
ZIKV isolates collected before 2012, the 188th residue of the NS1 protein is an alanine.
However, this residue is mutated to valine in all isolates after 2013 (Extended Data Fig. 6),
suggesting that the Asian linage of ZIKV evolved to acquire NS1 secretability when it
spread from Southeastern Asia to the Southern Pacific islands around 2013.
Correspondingly, Singapore reported local ZIKV transmission in August 2016. The
Singaporean strains stemmed from an ancestral node of the Asian lineage25. Indeed, in all
ZIKV isolates from Singapore, the 188th residue of the NS1 protein is a valine (Extended
Data Fig. 6), suggesting that the alanine-to-valine substitution may have contributed to the
recent ZIKV epidemics. Therefore, we synthesized the prM-E-NS1 genes from a Malaysia
P6-740 strain isolated in 1966 and a Micronesian 2007 strain and ectopically expressed these
genes in 293T cells. Compared to the secretion of NS1 in the supernatants of GZ01 prM-ENS1-transfected cells, the NS1 protein was hardly detectable in the supernatants of these
pre-epidemic ZIKV prM-E-NS1-expressing cells (Fig. 3c). However, the alanine-to-valine
mutation in the NS1 protein of the P6-740 strain conferred NS1 secretability (Fig. 3d).
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Next, we created the alanine-to-valine mutation at the 188th position of the NS1 protein in an
infectious clone of the FSS13025 strain (FSS13025-A188V)26. The substitution significantly
increased NS1 secretion in the supernatant of infected Vero cells (Extended Data Fig. 7a–c).
The FSS13025-A188V strain showed higher ZIKV infectivity in mosquitoes than wild type
virus (Extended Data Fig. 7d, e). In the "mouse-mosquito" acquisition model, NS1
antigenemia was increased in the sera of FSS13025-A188V ZIKV-infected mice (Fig. 3e).
Mutation of the NS1 188th position did not influence viral infectivity or dissemination
kinetics in infected AG6 mouse blood (Fig. 3f). However, the substitution enhanced ZIKV
transmission from mice to mosquitoes (Fig. 3g, h). Moreover, neutralization of NS1 with
murine ZIKV NS1 antisera effectively reduced the prevalence of FSS13025-A188V ZIKV in
mosquitoes (Extended Fig. 8a–d), highlighting that the 188th valine in NS1 has a critical role
in the antigenemia, which is critical for ZIKV acquisition by mosquitoes.

Author Manuscript

We next investigated whether NS1-mediated enhancement of ZIKV infectivity influences
the prevalence of ZIKV-carrying mosquitoes using a "mosquito-mouse-mosquito"
transmission cycle. We thoracically inoculated an equal titer (5 pfu) of the GZ01, FSS13025
and FSS13025-A188V mutant strains, into female A. aegypti mosquitoes. Six days
following virus inoculation, two infected mosquitoes were allowed to feed on AG6 mice
(Fig. 4a). The mosquito-bitten animals developed high-titer viremia of all three ZIKV strains
(Fig. 4b). Replication of both the GZ01 and FSS13025-A188V ZIKV strains, but not the
FSS13025 strain, resulted in efficient NS1 antigenemia (Fig. 4c). Subsequently, the infected
mice were subjected to daily biting by naïve A. aegypti from days 1 to 8 post-mouse
infection (Fig. 4a). Through a complete transmission cycle, the FSS13025-A188V strain
showed a significantly higher prevalence of mosquito infection than did the FSS13025 strain
(Fig. 4d, e), demonstrating that the 188th valine is required for the generation of NS1
antigenemia which enhances ZIKV transmissibility from hosts to vectors.
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ZIKV independently separated into African and Asian lineages. We found that the 188th
residue in all ZIKV African strains is valine (Extended Data Fig. 9a). The Uganda MR766infected Vero cells abundantly secreted NS1 (Extended Data Fig. 9b–d), implicating that
infection of the African ZIKV might produce high NS1 antigenemia. ZIKV has two
ecologically distinct transmission cycles: a sylvatic cycle (mosquitoes to non-human
primates) and a human cycle (mosquitoes to humans)27. Knowledge of ZIKV before 2012
was almost exclusively centered on the enzootic sylvatic cycle in Africa27,28. A mosquito
survey in Africa showed that ZIKV was detected in mosquitoes collected in multiple
surveyed landscapes, except for indoor locations within villages28. Therefore, we
hypothesize that the presence of the NS1 188th valine might bestow the African lineage of
ZIKV with a highly efficient enzootic or epizootic transmission cycle27,28. Other unknown
factor(s) might prevent African ZIKV from efficiently establishing a human cycle. However,
the Asian strains may have evolved to target humans with high infectivity; indeed, one such
strains caused a medium-scale epidemic in Micronesia in 20072,6. The alanine-to-valine
substitution at position 188 further improved ZIKV transmission efficiency from humans to
mosquitoes and thus increased its prevalence in mosquitoes. Our data offer a potential
explanation for the recent re-emergence of ZIKV, and suggest that coevolution of
arboviruses with their hosts/vectors contributes to their long-term existence in nature and
occasional widespread re-emergence.

Author Manuscript
Methods

Ethics statement
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Human blood for mosquito feeding was taken from healthy donors who provided written
informed consent. The collection of human blood samples was approved by the local ethics
committee at Tsinghua University.
Mice, mosquitoes, cells and viruses

Author Manuscript

AG6 mice were donated from Institute Pasteur of Shanghai, Chinese Academy of Sciences5.
The mice were bred and maintained under a specific pathogen-free animal facility at
Tsinghua University. Groups of age- and sex-matched AG6 mice, 6–8 weeks of age, were
used for the animal studies15. All experiments were approved by and performed under the
guidelines of the Experimental Animal Welfare and Ethics Committee of Tsinghua
University. A. aegypti (Rockefeller strain) were reared in a low-temperature, illuminated
incubator (Model 818, Thermo Electron Corporation, Waltham, MA) at 28 °C and 80%
humidity according to standard rearing procedures29. The ZIKV GZ01 strain (KU820898),
PRVABC59 (KU501215), SZ01 strain (KU866423), MR766 (NC_012532) and FSS13025
strain (KU955593) were grown in Vero cells for blood meals15. The Drosophila
melanogaster S2 cell line was cultured in Schneider’s medium with 10% heat-inactivated
fetal bovine serum and 1% antibiotic–antimycotic (15240-062, Invitrogen). The Vero cells
and 293T cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco)
supplemented with 10% heat-inactivated fetal bovine serum (16000-044, Gibco). For ZIKV
infection, the Vero cells were maintained in VP-SFM medium (11681-020, Gibco). The Vero
and 293T cell lines were purchased from the ATCC (CCL-81, CRL-3216). The Drosophila
S2 cell line was sourced from a Drosophila expression system of Invitrogen (R690-07).
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None of these cell lines were found in the database of commonly misidentified cell lines
maintained by ICLAC and NCBI Biosample. All these cell lines were authenticated by
ATCC or Invitrogen and do not have mycoplasma contamination. ZIKV was titered by a
plaque formation (PFU) assay29.
Antibodies

Author Manuscript

The ZIKV NS1 genes were amplified from the cDNA of infected cells and cloned into a
pET-28a (+) expression vector (69864, Millipore). The cloning primers are presented in
Extended Data Table 1. Recombinant NS1 proteins were expressed in the Escherichia coli
BL21 DE3 strain in an insoluble form in inclusion bodies. The proteins were then
solubilized by 8 M urea and purified with a TALON Purification Kit (635515, Clontech).
Murine antisera were produced via the inoculation of recombinant ZIKV NS1 with 3 boosts.
Polyclonal antibodies were purified from the immunized antisera using Protein A/G agarose
(20423, Thermo). The anti-V5-HRP antibody for tag detection were purchased from
Invitrogen (R96125, Thermo).
Expression of prM-E-NS1 protein in human cells

Author Manuscript

The prM-E-NS1 regions (820 bp-3438 bp in GZ01 KU820898; 927 bp-3544 bp in
FSS13025 KU955593) were amplified from cDNA of infected cells. The prM-E-NS1 genes
from the P6-740 strain (820 bp-3438 bp, HQ234499) and the Micronesian 2007 strain (820
bp-3438 bp, EU545988) were commercially synthesized (Genescript, China). All the genes
were subcloned into a pcDNA3.1/V5-His/TOPO DNA vector (K4800-01, Invitrogen), and
subsequently transfected by the X-treme Gene HP DNA transfection reagent (06366236001,
Roche) for ectopically expression in 293T cells. The amount of NS1 was determined in the
supernatants of the 293T cells at 48 hrs post-transfection. The cloning primers are shown in
Extended Data Table 1.
ZIKV NS1 protein generation in a Drosophila expression system
The ZIKV NS1 gene was cloned into a pMT/BiP/V5-His A vector (V4130-20, Invitrogen)
for expression in Drosophila S2 cells. The cloning primers are shown in Extended Data
Table 1. The procedure for ZIKV NS1 expression and purification in a Drosophila
expression system has been described in our previous studies15,29.
ZIKV NS1 detection by ELISA

Author Manuscript

Secretion of ZIKV NS1 into Vero cell supernatant and mouse serum was measured using a
ZIKV NS1 Antigen ELISA Kit (ZIKV-NS1-EK, BioFront MonoTrace). The experiment was
performed according to the kit’s manual. Samples were diluted to the range of quantification
of the kit using the sample dilution buffer provided in the kit. Standard materials for the
generation of a standard curve were also provided in the kit. The measured amount of ZIKV
NS1 matched the linearity in the assay. Optical density (OD) was measured at 450 nm with
an ELISA reader (Varioskan Flash Multimode Reader, Thermo Scientific). The detection
limit of NS1 protein by ELISA is 0.1 ng/ml.
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Detailed procedures for microinjection in mosquitoes have been described by our previous
studies15,30. Briefly, the female A. aegypti mosquitoes were anesthetized on a cold tray, and
subsequently a certain titer of ZIKV was microinjected into the mosquito thoraxes. The
infected mosquitoes were used for ZIKV transmission to AG6 mice by a blood meal.
Membrane blood feeding

Author Manuscript

Fresh human blood was placed in heparin-coated tubes (367884, BD Vacutainer) and
centrifuged at 1,000×g and 4 °C for 10 min to separate the plasma from the blood cells. The
plasma was collected and heat-inactivated at 55 °C for 60 min. The separated blood cells
were washed 3 times with PBS to remove the anticoagulant. The cells were then
resuspended in the heat-inactivated plasma. The donor's sera were negative for detection of
the E and NS1 proteins of JEV, DENV and ZIKV. Either purified proteins or antibodies were
mixed with the ZIKV-infected supernatant and human blood for mosquito oral feeding via a
Hemotek system (6W1, Hemotek Limited, England). Engorged female mosquitoes were
transferred into new containers and maintained under standard conditions for an additional 8
days. The mosquitoes were subsequently sacrificed for further analysis.
Mosquito feeding on infected mice

Author Manuscript

Eight to ten female A. aegypti mosquitoes were separated into a netting-covered container
for blood feeding. The mosquitoes were starved for 24 hr before engorgement. ZIKVinfected AG6 mice were anesthetized and placed on top of the container. The mosquitoes
were allowed to feed on the mice for 30 min in the dark. After anesthetization using ice, the
engorged mosquitoes were transferred to new containers and maintained under standard
conditions for an additional 8 days. The mosquitoes were subsequently sacrificed for further
analysis.
Purification of infectious ZIKV virions
The procedure of purification of flaviviral infectious virions has been described in our
previous study15. Briefly, supernatant from GZ01-infected Vero cells was collected 5 days
after infection. Cell fragments were removed by centrifugation at 25,000×g and 4 °C for 20
min. Subsequently, the supernatant was carefully transferred into a clean centrifuge tube and
centrifuged at 25,000×g and 4 °C for an additional 6 h to pellet the virions. The precipitated
virions were washed twice and then solubilized in VP-SFM medium (11681-020, Gibco).
Insoluble material was removed by an extra centrifugation step at 12,000×g and 4 °C for 2
min. The virions in the VP-SFM medium were aliquoted and stored at -80 °C.
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Viral genome quantitation by TaqMan qPCR
Total RNA was isolated from homogenized mosquitoes using an RNeasy Mini Kit (74106,
Qiagen) and reverse-transcribed into cDNA using an iScript cDNA synthesis kit (170-8890,
Bio-Rad). Viral genomes were quantified via TaqMan qPCR amplification of ZIKV genes,
normalized against A. aegypti actin (AAEL011197). The detection limit of ZIKV E/Actin
mRNA ratio is 0.001. The primers and probes used for this analysis are shown in Extended
Data Table 1.

Nature. Author manuscript; available in PMC 2018 April 05.

Liu et al.

Page 8

Determination of the virus titer in infected mice by plaque assay
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Blood samples were collected from the tail veins of infected mice in 0.4% sodium citrate
and were centrifuged for 5 min at 6,000×g and 4 °C for plasma isolation. The presence of
infectious viral particles in the plasma was determined using a plaque assay15. The detection
limit in the plaque assay is 10 pfu/ml in cell supernatant, and 100 pfu/ml in serum.
RNA transcription, transfection and virus recovery

Author Manuscript

The pFLZIKV-FSS13025 and pFLZIKV-FSS13025-A188V26 plasmids were amplified in E.
coli Top10 (C404010, Invitrogen) and purified using MaxiPrep PLUS (12965, QIAGEN).
For in vitro transcription, 10 μg of plasmid was linearized with the restriction enzyme ClaI.
A mMESSAGE mMACHINE T7 kit (AM1344, Ambion) was used for in vitro transcription
of RNA in a 20 μl reaction with an additional 1 μl of 30 mM GTP solution. The RNA was
precipitated with lithium chloride and quantified via spectrophotometry. Subsequently, the
RNA was transfected into Vero cells seeded in a T175 flask with DMEM medium and
incubated at 37°C and 5% CO2 using Lipofectamine 3000 reagent (L3000015, Invitrogen).
Recombinant viruses in cell culture media were harvested 4 days post transfection, stored in
aliquots at -80°C, and subjected to further investigation.
Statistics

Author Manuscript

Animals were randomly allocated into different groups. Mosquitoes that died before
measurement were excluded from analysis. The investigators were not blinded to the
allocation during the experiments or to the outcome assessment. No statistical methods were
used to predetermine the sample size. Descriptive statistics have been provided in the figure
legends. Kruskal-Wallis analysis of variance was conducted to detect any significant
variation among replicates. If no significant variation was detected, the results were pooled
for further comparison. Given the nature of the experiments and the type of samples,
differences in continuous variables were assessed with a non-parametric Mann-Whitney test.
Differences in mosquito infective rates were analyzed using Fisher’s exact test. p values
were adjusted using Bonferroni correction to account for multiple comparisons. All analyses
were performed using GraphPad Prism statistical software.
Data availability
Source data for the main and Extended Data Figures are provided in the online version of
this paper. All other data are available from the corresponding authors upon reasonable
request.
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Extended Data
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Extended Data Figure 1. Phylogenetic analysis of ZIKV isolates in the Asian lineage

The tree was constructed using the neighbor-joining (NJ) method based on the alignment of
ZIKV sequences in the Asian lineage. The bootstrap values of 2000 replicates are indicated
on the branch nodes.
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Extended Data Figure 2. Generation of murine anti-ZIKV NS1 polyclonal antibody and
purification of the GZ01 ZIKV NS1 protein from Drosophila S2 cells

Author Manuscript

a, Generation of murine anti-ZIKV NS1 polyclonal antibody. A murine ZIKV NS1
polyclonal antibody was generated by immunization of the purified GZ01 ZIKV NS1
recombinant protein expressed in E. coli. The antibody was validated by probing an S2expressed ZIKV NS1 recombinant protein. The same samples probed by murine preimmune antibody served as a negative control.
b, Purification of the GZ01 ZIKV NS1 protein from Drosophila S2 cells. Full-length NS1
was cloned into the pMT/BiP/V5-His A expression vector. Recombinant ZIKV NS1 protein
was expressed in Drosophila S2 cells and purified using a cobalt-His column (Left Panel).
Protein quality was evaluated by Western-blotting with an anti-V5 antibody (Right Panel).
a, b, The experiments were reproduced 3 times with similar results. For gel source data, see
Supplementary Fig. 1.
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Extended Data Figure 3. Anti-ZIKV NS1 antibodies did not neutralize ZIKV virions
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We premixed two dilutions of murine ZIKV NS1 polyclonal antisera (1:100 and 1:1000)
with purified ZIKV GZ01 infectious virions. The same amount of pre-immune sera served
as a negative control. After a 30 min incubation, the infectivity of the "antibody-ZIKV
virion" mixture was determined by plaque assay on Vero cells. The values in the graph
represent the mean ± s.e.m. p values were determined by two-tailed Mann-Whitney test. The
data were combined from 3 biological repeats. n.s., not significant.
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Extended Data Figure 4. Passive transfer of ZIKV NS1 antibodies into infected AG6 mice
prevented ZIKV acquisition by A. aegypti

a, Schematic representation of the study design. AG6 mice were intradermally infected with
1×104 pfu of the ZIKV GZ01 strain. Subsequently, 100 μl of a murine ZIKV NS1 antibody
was intraperitoneally inoculated into the mice 12 hr post-infection. The same amount of preimmune serum was inoculated as a mock control. After 12 hr of antibody dissemination, the
infected mice were subjected to daily biting by female A. aegypti from day 1 to day 5 post-
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mouse infection. The mouse blood-fed mosquitoes were reared for an additional 8 days for
ZIKV detection.
b, ZIKV NS1 measurement by ELISA (n=6 mice per group pooled from 3 independent
biological replicates). Mouse sera were collected to quantify the amounts of ZIKV NS1
protein from days 0 and 6 post-mouse infection.
c, Detection of the ZIKV load in the blood of the infected mice (n=8 mice per group pooled
from 4 independent biological replicates). The presence of infectious ZIKV particles in
blood plasma was determined by a plaque assay from days 0 to 6 post-mouse infection.
d, e, Immuno-blockade of ZIKV NS1 in infected AG6 mice reduced the infection of fed A.
aegypti (n=6 mice per group pooled from 3 independent biological replicates). The number
of infected mosquitoes relative to the total number of mosquitoes is shown at the top of each
column. Each dot represents a mosquito (d). The data are represented as the percentage of
mosquito infection (e).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test
(b-d) or two-sided Fisher’s exact test (e). **p< 0.01, ***p< 0.001, n.s., not significant.
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Extended Data Figure 5. Modeling the location of the 188th residue of ZIKV NS1 and assessing
NS1 dimer formation in cell lysates

Author Manuscript

a, Modeling the location of the 188th residue of ZIKV NS1. Modeling was based on the
ZIKV NS1 structure (PDB: 5K6K)30. The 188th position is located within the interface of a
NS1 dimer (contoured by red), which is formed by hydrophobic interactions. The 188th
amino acid is deep within the hydrophobic pocket formed by Trp-210, Leu-23, His-299 and
Leu-231.
b, Assessing NS1 dimer formation in the lysates of cells transfected with GZ01 or
FSS13025 prM-E-NS1 recombinant plasmids. The cell lysates, with or without heating
treatment, were used for assessing NS1 monomer and dimer by Western blotting with an
anti-V5 antibody, respectively. The experiment was reproduced 3 times with similar results.
For gel source data, see Supplementary Fig. 1.
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Extended Data Figure 6.

Sequence alignment of NS1 sequences in ZIKV isolates of the Asian lineage.
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Extended Data Figure 7. A single amino acid substitution enhanced NS1 secretability and ZIKV
infectivity in mosquitoes

Author Manuscript

a–c, NS1 secretability in ZIKV-infected Vero cells. We mutated the single amino acid from
alanine to valine at the 188th position of NS1 protein on an infectious clone of ZIKV
Cambodian FSS13025 strain (FSS13025-A188V strain). FSS13025 or FSS13025-A188V
strain (0.01 M.O.I.) was used to infect Vero cells. Supernatants from the infected Vero cells
were collected from 0 to 5 days post-infection. a, The amount of ZIKV NS1 protein was
determined by ELISA. b, ZIKV titer was determined by a plaque assay. c, NS1 quantity
normalized against average viral titer (ng per pfu). The data were pooled from 3 independent
biological replicates.
d–e, NS1 secretability determined ZIKV infectivity in mosquitoes. The supernatant, isolated
from the FSS13025-infected or FSS13025-A188V-infected Vero cells, was premixed with
fresh human blood at a 1:1 ratio for an in vitro membrane feeding experiment (final titer is
5×104 pfu/ml), respectively. The fed mosquitoes were scarified on 8 days after a blood meal
to determine the ZIKV load by qPCR. The number of infected mosquitoes relative to the
total number of mosquitoes (infected number/total number) is shown at the top of each

Nature. Author manuscript; available in PMC 2018 April 05.

Liu et al.

Page 17

Author Manuscript

column. Each dot represents a mosquito (d). The data are represented as the percentage of
mosquito infections (e). The data were pooled from 3 independent biological replicates.
Data are mean ± s.e.m. (a-c). p values were determined by two-tailed Mann-Whitney test (ad) or two-sided Fisher’s exact test (e). *p< 0.05, **p< 0.01, n.s., not significant.
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Extended Data Figure 8. Neutralization of NS1 by murine ZIKV NS1 antisera effectively
reduced the prevalence of FSS13025-A188V ZIKV in A. aegypti

Author Manuscript

a, b, Infection by FSS13025-A188V ZIKV in AG6 mice. The AG6 mice were intradermally
inoculated with these viruses (1×104 pfu). ZIKV NS1 measurement by ELISA. Mouse sera
were collected to qualify the amounts of ZIKV NS1 protein from days 0 to 6 post-mouse
infection (a). Detection of the ZIKV load in the blood of infected AG6 mice. The presence
of infectious ZIKV particles in blood plasma was determined by a plaque assay (b). n=10
mice per group pooled from 4 independent biological replicates.
c, d, Immuno-blockade of NS1 in the FSS13025-A188V ZIKV infected AG6 mice reduced
the acquisition of fed A. aegypti (n=7 mice per group pooled from 3 independent biological
replicates). The number of infected mosquitoes relative to the total number of mosquitoes is
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shown at the top of each column. Each dot represents a mosquito (c). The data are
represented as the percentage of mosquito infection (d).
Data are mean ± s.e.m. (a, b). p values were determined by two-tailed Mann-Whitney test
(a-c) or two-sided Fisher’s exact test (d). *p< 0.05, ***p< 0.001, n.s., not significant.
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Extended Data Figure 9. Sequence alignment of NS1 sequences in African ZIKV isolates, and
NS1 secretability in African ZIKV-infected Vero cells

Author Manuscript

a, Sequence alignment of NS1 sequences in African ZIKV isolates.
b-d, NS1 secretability in African ZIKV-infected Vero cells. Vero cells were infected at an
M.O.I. of 0.01 with the GZ01, FSS13025 and MR766 strains. Supernatants from the infected
Vero cells were collected from 0 to 4 days post-infection. b, ZIKV titer was determined by a
plaque assay. c, The amount of ZIKV NS1 protein was determined by ELISA. d, NS1
quantity normalized against average viral titer (ng per pfu). The data were pooled from 3
independent biological replicates.
The values in the graph represent the mean ± s.e.m. (b-d).
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Figure 1. Comparing the infectivity of ZIKV isolates of Asian lineage in mosquitoes
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a, Schematic representation of the study design. Separated groups of AG6 mice were
intradermally infected with 1×104 pfu of the GZ01 and FSS13025 strains.
b, Detection of the ZIKV load in the blood plasma by a plaque assay (n=14 mice per group
pooled from 5 independent biological replicates).
c, ZIKV NS1 measurement by ELISA (n=6 mice per group pooled from 3 independent
biological replicates).
d, e, Comparison of the infectivity of two ZIKV isolates in A. aegypti (n=6 mice per group
pooled from 3 independent biological replicates). The number at the top of each column
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represents infected number/total number. Each dot represents a mosquito (d). The data are
represented as the percentage of mosquito infections (e).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test
(b-d) or two-sided Fisher’s exact test (e). **p< 0.01, ***p< 0.001, n.s., not significant.

Author Manuscript
Author Manuscript
Author Manuscript
Nature. Author manuscript; available in PMC 2018 April 05.

Liu et al.

Page 23

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Figure 2. Differences in NS1 secretion determine ZIKV infectivity in mosquitoes

a-c, NS1 secretability in ZIKV-infected Vero cells. Vero cells were infected with 0.01 M.O.I.
viruses. c, NS1 quantity normalized against average viral titer (ng per pfu). The data were
pooled from 3 independent biological replicates.
d-f, Immunoblockade of NS1 in GZ01-infected supernatants reduced ZIKV acquisition.
Either 10 μl of murine ZIKV NS1 antisera or pre-immune sera were mixed with supernatant
from ZIKV GZ01-infected Vero cells (500 μl) and fresh human blood (500 μl) for in vitro
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membrane feeding of A. aegypti. The data were pooled from 2 independent biological
replicates.
g-i, Addition of NS1 in FSS13025-infected supernatant increased the mosquito infection.
Either 10 μg of purified NS1 or BSA was incubated with fresh human blood (500 μl) and
supernatant from ZIKV FSS13025-infected Vero cells (500 μl) to feed A. aegypti. The data
were pooled from 2 independent biological replicates.
j-l, Assessment of the threshold NS1 concentration that enhances ZIKV acquisition. Serial
dilutions of purified ZIKV NS1 (10 μl) were mixed with purified GZ01 ZIKV virions (10 μl)
and fresh human blood (1000 μl) for A. aegypti feeding. The data were pooled from 4
independent biological replicates.
A final concentration of 1×105 pfu/ml ZIKV was used for mosquito oral infection (d, g, j).
The number at the top of each column represents infected number/total number. Each dot
represents a mosquito (e, h, k).
Data are mean ± s.e.m. (a-c). p values were determined by two-tailed Mann-Whitney test (e,
h, k) or two-sided Fisher’s exact test (f, i, l), and adjusted using Bonferroni correction to
account for multiple comparisons (k, l). The p value represents a comparison between BSA
and other groups (k, l). *p< 0.0125, ***p< 0.00025, n.s., not significant.
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Figure 3. A single amino acid residue in NS1 determines its secretability in the Asian lineage of
ZIKV
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a, Comparison of the prM-E-NS1 sequence between GZ01 and FSS13025 isolates.
b, Detection of NS1 secretion in ectopically expressed prM-E-NS1 proteins of the subcloned
and mutated GZ01 and FSS13025 strains.
c, Detection of NS1 secretion in ectopically expressed prM-E-NS1 proteins of ZIKV Asian
strains.
d, Mutation of alanine to valine in the NS1 protein conferred NS1 secretability to the prME-NS1 proteins of a Malaysia P6-740 strain.
b-d, The experiments were reproduced 3 times with similar results. For gel source data, see
Supplementary Fig. 1.
e, Measurement of ZIKV NS1 antigenemia by ELISA (n=10 mice per group pooled from 5
independent biological replicates).
f, Detection of the ZIKV load in the mouse blood by a plaque assay (n=8 mice per group
pooled from 4 independent biological replicates).
g, h, Comparison of mosquito infectivity (g) and infective ratio (h) of ZIKV strains (n=6
mice per group pooled from 3 independent biological replicates). The number at the top of
each column represents infected number/total number. Each dot represents a mosquito (g).
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The AG6 mice were intradermally inoculated with 1×104 pfu of the FSS13025 and
FSS13025-A188V strains, data are mean ± s.e.m. (e, f). p values were determined by twotailed Mann-Whitney test (e-g) or two-sided Fisher’s exact test (h). *p< 0.05, ***p< 0.001,
n.s., not significant.
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Figure 4. A single amino acid substitution influences the prevalence of mosquito infection during
the "mosquito-host-mosquito" life cycle
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a, Schematic representation of the study design.
b, Detection of the ZIKV viremia by a plaque assay (n=12 mice per group pooled from 4
independent biological replicates).
c, Measurements of ZIKV NS1 antigenemia by ELISA (n=12 mice per group pooled from 4
independent biological replicates).
d, e, Comparison of mosquito infectivity (d) and infective ratio (e) of ZIKV strains (n=9
mice per group pooled from 3 independent biological replicates). The number at the top of
each column represents infected number/total number. Each dot represents a mosquito (d).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test
(b-d) or two-sided Fisher’s exact test (e), and adjusted using Bonferroni correction to
account for multiple comparisons (b-e). The black p value represents a comparison between
GZ01 and FSS13025. The blue p value represents a comparison between FSS13025-A188V
and FSS13025. *p< 0.025, **p< 0.005, ***p< 0.0005, n.s., not significant.
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Upper primer

TAAGGCGGTACCGCCACCATGCAAAAAGTCATATAC

ATGTGGTTGGGTCTGAATACAAAGAATGGA

ATTGGAACAGCCGCTAAGGGAAAGGAGGCT

GTCATAGGAACAGCTGTTAAGGGAAAGGAG

Upper primer

CCGCTGCCCAACACAAG

GAACACCCAGTCCTGCTGACA

AGCCATGTACGTAGCCATCCA

Primers for cloning
into pcDNA3.1/V5His/TOPO

Zika prM-E-NS1
(V5 Tag in Cterminal)

FSS13025 V-M
mutation (E)

FSS13025 A-V
mutation (NS1)

P6-740 A-V
mutation (NS1)

The primers for
Taqman RT-qPCR

ZIKV envelope gene

Aedes aegypti actin

Mouse actin

Upper primer

Primers for cloning
into pMT/BiP/V5His/A

TCTCGGGGTACCTGATGTGGGGTGCTCG

TATCTAGCTAGCGATGTGGGGTGCTCG

ZIKV NS1 (His tag
m both N and Cterminal)

ZIKV NS1 (V5 tag
in C-terminal)

Upper primer

Primers for cloning
into pET28a(+)
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Primers and probes for gene cloning and qPCR.
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TCTCCGGAGTCCATCACAATG

TGCGTCATCTTCTCACGGTTAG

CCACTAACGTTCTTTTGCAGACAT

Lower primer

CTCCTTTCCCTTAACAGCTGTTCCTATGAC

AGCCTCCTTTCCCTTAGCGGCTGTTCCAAT

TCCATTCTTTGTATTCAGACCCAACCACAT

TATCCGCTCGAGCGTGCAGTCACCATTGA

Lower primer

TATTACGCTCGAGTGCAGTCACCATTGAC

Lower primer

GATTCCGCTCGAGTGCAGTCACCATTGA

Lower primer

FAM-TGTCCCTGTATGCCTCTGGTCGTACCAC-TAMRA

FAM-AGGCCCCGCTCAACCCGAAG-TAMRA

FAM-AGCCTACCTTGACAAGCARTCAGACACTCAA-TAMRA

Probe (for Taqman QPCR)
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